NAFLD Fibrosis Score Calculator

NAFLD Fibrosis Score Calculator

Estimate advanced fibrosis in fatty liver disease from age, BMI, glycaemic status, AST/ALT ratio, platelets and albumin.

NAFLD Fibrosis Score

6 inputs → score
Divide g/L by 10.
0.708NFSExample

Age 55, BMI 32, diabetes present, AST 48, ALT 40, platelets 190, albumin 3.8 g/dL

Formula

NFS = −1.675 + (0.037 × age) + (0.094 × BMI) + (1.13 × IFG/diabetes) + (0.99 × AST/ALT) − (0.013 × platelets) − (0.66 × albumin)
age
years
BMI
kg/m²
IFG/diabetes
1 if present, 0 if absent
AST/ALT
ratio of the two in U/L
platelets
×10⁹/L
albumin
g/dL — divide g/L by 10

Worked example

Age 55, BMI 32, diabetes present, AST 48, ALT 40, platelets 190, albumin 3.8 g/dL
AST/ALT = 48 ÷ 40 = 1.20
−1.675 + (0.037×55) + (0.094×32) + 1.13 + (0.99×1.20) − (0.013×190) − (0.66×3.8)
= −1.675 + 2.035 + 3.008 + 1.130 + 1.188 − 2.470 − 2.508 = 0.708
Above 0.675 → advanced fibrosis likely

Thresholds

ScoreInterpretationPredictive value
< −1.455Advanced fibrosis unlikelyNPV ≈ 93%
−1.455 to 0.675Indeterminate
> 0.675Advanced fibrosis likelyPPV ≈ 90%
About a third of patients fall in the indeterminate band, which is the score's main practical limitation.

Using the score in a fatty liver pathway

The NAFLD fibrosis score was derived specifically in biopsied fatty liver disease, and unlike the more general indices it includes BMI and glycaemic status — the two metabolic drivers that determine who progresses. That makes it better calibrated than APRI in this population, though FIB-4 is simpler and performs comparably.

It is used the same way as FIB-4: as a rule-out test at the front of a pathway. A score below −1.455 makes advanced fibrosis unlikely enough to keep a patient in primary care, which is what a condition affecting a quarter of the adult population requires. A score above 0.675 warrants referral.

Two limitations matter in practice. About a third of patients land in the indeterminate band and need a second test regardless, so many pathways now run FIB-4 first and reserve elastography for the indeterminate and high groups. And like FIB-4, the score drifts upward with age because age is a positive term, so it over-calls fibrosis in older patients — the same caution that produced the age-adjusted FIB-4 threshold applies here, without an agreed correction.

Frequently asked questions

What albumin units does the NAFLD fibrosis score use?

g/dL. If your laboratory reports g/L, divide by 10 — an albumin of 38 g/L is 3.8 g/dL. Using g/L directly produces a wildly wrong score.

What counts as impaired fasting glucose for this score?

A fasting glucose of 100 mg/dL (5.6 mmol/L) or above, or an established diagnosis of diabetes. Either scores 1.

How does it compare with FIB-4?

Similar accuracy in fatty liver disease. FIB-4 needs fewer inputs and no BMI, so most pathways use it first; the NAFLD fibrosis score adds metabolic variables and is a reasonable second opinion.

What do I do with an indeterminate result?

Proceed to a second non-invasive test — transient elastography or an ELF blood test — rather than to biopsy. Around a third of patients score in this band.

Related calculators

References

  1. Angulo P et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.
  2. EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD.